ADAM17 and Alzheimer disease: This shows the capacity of TiO2- and CB-NPs to enhance the production of neurotoxic Aβ peptides of Alzheimer’s disease through their interaction with PrPC and subversion of PrPC coupling to the PDK1-TACE-APP pathway.